In addition, a role of ERα-LBD in breast cancer stemness and malignancy was suggested by RNA-seq analysis and qPCR demonstrating an enrichment of the ESR1-LBD transcript in fulvestrant resistant CD44High tumor cells (Supplementary Fig. 7). The gene discussed is ESR1; the disease is breast carcinoma.